Clinical Trials Logo

Clinical Trial Summary

Patients with refractory GERD on BID PPI's assigned to the acupuncture group will have significant improvement in their symptoms after receiving acupuncture for 6 weeks as compared to sham acupuncture given for the same duration.

Primary Aim 1:To determine the efficacy of acupuncture in the treatment of refractory GERD.

Participants with refractory GERD on BID PPIs randomized to yoga will have a significant relief in the symptoms of reflux.

Primary Aim 2:To determine the efficacy of yoga in the treatment of refractory GERD.


Clinical Trial Description

BACKGROUND

Prevalence and burden of disease:

Gastroesophageal reflux disease (GERD) defined as presence of symptoms of heartburn and/or acid regurgitation is a common chronic disorder. It is a significant health problem especially in the Western population associated with a huge economic burden and impaired quality of life (1, 2). The prevalence of GERD in the adult population of the United States is 40% (symptoms at least once a month). Approximately 20% report GERD related symptoms weekly while 14% report them on a daily basis.

The leading gastrointestinal symptoms evaluated in a primary care office setting are those related to a diagnosis of GERD. The mainstay of treatment for GERD symptoms at present time are proton pump inhibitors (PPI) in combination with life style changes. In fact, PPI have become one of the most commonly written prescriptions, trends suggesting that per year scripts have doubled since 1999. It is estimated that Americans spend in excess of 10 billion US dollars/year on PPIs and two of the top five selling drugs in the United States are PPIs (5). For patients who prefer to refrain from long-term medication use, may benefit from acid-reflux surgeries such as Nissen fundoplication. However, acid-reflux reducing procedures are associated with operative morbidity and mortality including several complications including gas bloat syndrome. A large number of patients who undergo surgery for reflux symptoms may eventually relapse and require PPIs. Thus, treatment of reflux, either pharmacological or surgical, is costly (6-9) and presents a significant economic burden on the health-care delivery system.

Social Impact of the disease:

GERD symptoms are associated with bodily pain, impaired social, emotional and physical functioning which has a profound impact on daily living. Much research has been done to evaluate the true burden of GERD on our society. For instance, 40% of patients with nighttime symptoms of GERD reported that such symptoms affected their ability to function the next day. Furthermore, 27% of these patients reported that their own night-time symptoms affected their spouses ability to sleep (10). Clearly, this data indicates a huge number of Americans who report the effects of heartburn on personal and spousal quality of life. GERD symptoms need to be addressed effectively as successful treatment for GERD results in improvements in health related quality of life (11, 12). In the treatment of GERD, the goal should be complete symptom resolution as this has been shown to be associated with a clinically significant improvement in health related quality of life (HRQL) (13).

Refractory GERD:

Despite life style changes and compliant therapy with PPI, a large number of patients may have persistent symptoms and classified to have refractory GERD, a distinctive group that is difficult to manage (14). The putative reasons remain poorly defined but likely include contributions from factors such as non-acid reflux, visceral hypersensitivity, and abnormal esophageal motor events (14). A study by Tack et al investigated mechanisms for poor response to PPI therapy and showed persistence of acid reflux in 11%, bile reflux alone in 38% and a combination of acid and bile reflux in 26%. However, persistence of acid or bile reflux does not prove a causal relationship with symptoms (15). Also, in this group of individuals with acid or bile reflux on BID PPI's, a possible treatment option is Nissen's fundoplication, the utility of which is yet to be proven in this cohort. There is no consensus definition of refractory GERD and generally, it is defined as non-response of symptoms to optimum PPI trial. The goal of providing symptomatic relief to these refractory patients is extremely challenging in view of limited options. It is to these patients that the investigators would like to evaluate in a feasibility study the use of complementary medicine modalities including acupuncture and yoga that may be relatively safe, cost-effective therapies to help with the distressing symptoms of GERD.

Complementary and alternative medicine:

Complementary and alternative medicine (CAM) is a group of diverse medical and health care systems, therapies and products that are not presently considered to be part of conventional medicine. These methods have been used for centuries in the eastern culture for a myriad group of diseases. CAM became popular in the US in the 1990's where majority of people used it as a complement to conventional medicine and not as an alternative (16-18). Recently, there has been much interest in applying these modalities not as secondary therapies to conventional treatment but as the primary method. Amongst them acupuncture and yoga have gained a great deal of popularity.

Acupuncture (AC):

Acupuncture is part of the traditional Chinese medicine a complete system of healing that dates back to 200 BC. The general theory of acupuncture is based on the premise that there are patterns of energy flow (Qi) through the body that are essential for health and disruptions of this flow are believed to be responsible for disease. Studies have shown that AC modulates the endorphin system via the central pain processing pathways (19, 20). Acupuncture has been widely used for various gastrointestinal disorders. It is conceivable that acupuncture may be effective in patients with GERD because it has been shown to alter acid secretion, GI motility and visceral pain (21, 22).

The pathogenesis of GERD is multifactorial. The predominant mechanism postulated to cause GERD is transient relaxation of the lower esophageal sphincter (TLESR). Pathological reflux may also occur due to low LES pressures (23). Studies have shown that acupoint stimulation can decrease the rate of TLESR's and hence prevents reflux (24). The investigators propose to use 3 acupoints ST-36, PC-6, CV-12 for treatment of symptoms of GERD. These points are described in the subsequent sections. Acupuncture will be performed by Dr. Santosh Sharma who has the expertise in this treatment modality and is currently offering his therapy for several years at the Veterans Affairs Medical Center, Kansas City.

Yoga:

Yoga refers to a combination of breathing exercises and postures designed to involve specific muscle groups with systemic effects on the various organ systems. Yoga originated in India at least 3000 years ago. The practice of yoga came to US in 1890 and gained popularity in 1960s because of a rising interest in and cultural acceptance of alternative modalities and mind body therapies. Yoga is offered in local YWCA, health clubs and yoga centers and in hospitals as part of disease prevention and management programs (25).The most popular form is Hatha yoga. As discussed below, the usefulness of yoga has been studied in certain chronic illnesses such as back pain with promising results. The investigators propose to use yoga exercises specifically designed for reflux symptoms. Dr. Vijay Kumar will be offering yoga classes to patients with refractory GERD. Dr. Vijay Kumar is a Professor of Computer Science at University of Missouri - Kansas City and has been offering classes for several years at various levels.

Evidence for use of acupuncture and yoga:

Several randomized controlled trials have been conducted demonstrating the beneficial effects of acupuncture. A randomized controlled study in 29 patients with mild to moderate ulcerative colitis with a 4 month follow up after completion of acupuncture sessions showed a statistically significant improvement in colitis activity index (CAI) as compared to the control group. The study concluded that acupuncture provided an additional therapeutic benefit to patients with mild to moderate ulcerative colitis (26).

Another randomized 3-arm study was conducted to assess the efficacy and safety of traditional Chinese acupuncture compared with sham acupuncture (needling at defined non-acupuncture points) and conservative therapy in patients with chronic pain due to osteoarthritis of the knee. Addition of acupuncture led to significant improvement in the symptoms (27). Recently, Dickman et al evaluated the efficacy of adding acupuncture (twice a week over 4 weeks) as compared to doubling the PPI dose in 30 refractory GERD patients(28). The acupuncture group demonstrated a significant decrease in mean daytime heartburn scores compared to high-dose PPI group. Mean nighttime heartburn and regurgitation scores improved only in the acupuncture group. Thus this study showed that adding acupuncture as compared to doubling the PPI dose was more effective in controlling symptoms of GERD in patients on standard dose of PPI.

Similar benefits have been demonstrated with the use of yoga. A randomized controlled trial compared yoga, exercise and self care book for chronic low back pain showed that yoga was more effective than a self-care book for improving function and reducing chronic low back pain and the benefits persisted for at least several months (29). Yoga was also found to be useful in improving symptoms related to irritable bowel in a randomized trial conducted in Canada (30).

CLINICAL RELEVANCE OF THIS STUDY GERD is a well known, widely prevalent, clinical entity. The symptoms of GERD if not relieved can affect the daily functioning/productivity of individuals. This can be especially frustrating for some patients, who may spend hundreds of dollars every year on prescription medications, and are still not able to obtain relief of their symptoms. In the United States alone, it is estimated that PPI costs alone make up over $10billion/year (5). However, despite these staggering costs, it is clear that even PPI therapy is not the definitive answer for all patients. Indeed, it has been reported that 37% of patients receiving PPIs also note concomitant antacid use. This finding underscores the fact that even with PPI therapy, a large percentage of patients do not achieve full symptom relief. When left untreated--or when treated inadequately--severe GERD can progress to esophagitis, esophageal ulcers, esophageal strictures, laryngeal disease, chronic cough, Barrett's esophagus, and esophageal adenocarcinoma. Clearly, such patients with refractory symptoms are the ones in the direst need for additional modalities of therapy. Yoga and acupuncture may be a promising option for these patients, as they represent cost-effective, yet underused, options which may be usefully employed to control the symptoms of GERD.

Data Collection:

Patient demographics, order of randomization, responses to questionnaires, and antacid use will be collected by the study coordinator and recorded in a database.

RISK AND BENEFIT TO THE STUDY PARTICIPANT:

This pilot prospective study has the potential to identify new treatments for GERD symptoms. The participants in this study may experience relief from their GERD symptoms persistent on high dose acid suppressive therapy. This may improve their quality of life and level of functioning. The risks to the study group are minimal. There is minor risk of bruising, needle breakage and infection with the acupuncture needles and musculoskeletal symptoms in patients undergoing yoga. If the study shows significant improvement in reflux symptoms with acupuncture or yoga, then these methods may have a wider application to the entire spectrum of GERD symptoms with the prospect of avoiding pharmacologic and surgical therapies.

STATISTICAL METHODS AND DATA ANALYSIS:

Data Analysis:

Data will be analyzed with the help of a statistical software program. Categorical and continuous variables will be compared using the Student's t-test and chi-square test. A p value of < 0.05 will be considered significant. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00591877
Study type Interventional
Source Midwest Biomedical Research Foundation
Contact
Status Withdrawn
Phase N/A
Start date December 2012
Completion date January 2015

See also
  Status Clinical Trial Phase
Completed NCT02135107 - A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients Phase 3
Completed NCT01432392 - Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease N/A
Recruiting NCT01249482 - Symptom Assessment for GERD Patients Receiving H. Pylori Eradication N/A
Completed NCT01200550 - The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients N/A
Completed NCT01578642 - Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease Phase 2
Unknown status NCT01128608 - The Effect of High PCO2 Solution on Esophageal Acid Sensation N/A
Completed NCT00998244 - Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease N/A
Completed NCT00978016 - A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD) Phase 2
Completed NCT00768196 - Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients N/A
Completed NCT00768443 - Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD) N/A
Recruiting NCT00498082 - Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease N/A
Completed NCT00886197 - Diagnostic Efficacy of Narrow Band Imaging in Patients With Gastroesophageal Reflux Disease N/A
Completed NCT00378898 - Feasibility of Placing Bravo PH Capsule in Proximal Esophagus N/A
Completed NCT00507377 - Foreshortened Esophagus and Its Surgical Therapy
Completed NCT00217347 - Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy N/A
Completed NCT00165022 - Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population N/A
Completed NCT00214552 - Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. Phase 3
Completed NCT00625495 - Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) Phase 4
Completed NCT00618150 - Patient Education in Gastroesophageal Reflux Disease N/A
Completed NCT03299985 - Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease N/A